Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


2 Am J Gastroenterol
1 Eur J Gastroenterol Hepatol
3 Hepatology
1 J Hepatol
1 J Infect Dis
3 J Virol
1 Lancet
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Gastroenterol

  1. ZAMOR PJ, Vierling J, Ghalib R, Luketic V, et al
    Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials.
    Am J Gastroenterol. 2018 Apr 26. pii: 10.1038/s41395-018-0053.
    PubMed     Text format     Abstract available

  2. PERRELLA A, Rinaldi L, Galeota-Lanza A, Izzi A, et al
    DAAs and long-term clinical outcome in hepatitis C: the panacea for all diseases still does not exist.
    Am J Gastroenterol. 2018 Apr 24. pii: 10.1038/s41395-018-0062.
    PubMed     Text format    

    Eur J Gastroenterol Hepatol

  3. GOKCE O, Ozenirler S, Atak Yucel A, Oruklu N, et al
    Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2018 Apr 20. doi: 10.1097/MEG.0000000000001123.
    PubMed     Text format     Abstract available


  4. LIM TY, Martinez-Llordella M, Kodela E, Gray E, et al
    Low Dose Interleukin-2 for Refractory Autoimmune Hepatitis.
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30059.
    PubMed     Text format    

  5. YANG JD, Gores GJ
    Does Cirrhosis Associated with Well Controlled Viral Hepatitis Confer a Risk for Extrahepatic Cancer?
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30063.
    PubMed     Text format    

  6. WIRTH S, Zhang H, Hardikar W, Schwarz KB, et al
    Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children with Chronic Hepatitis B: The PEG-B-ACTIVE Study.
    Hepatology. 2018 Apr 24. doi: 10.1002/hep.30050.
    PubMed     Text format     Abstract available

    J Hepatol

  7. WANG L, Gao F, Lin G, Yuan Y, et al
    Association of hepatitis E virus infection and myasthenia gravis: A pilot study.
    J Hepatol. 2018 Apr 19. pii: S0168-8278(18)30133.
    PubMed     Text format    

    J Infect Dis

  8. MAY S, Mandal S, Keel P, Haywood B, et al
    Hepatitis B virus immunisation and neonatal acquisition of persistent infection in England and Wales.
    J Infect Dis. 2018 Apr 24. pii: 4982944. doi: 10.1093.
    PubMed     Text format     Abstract available

    J Virol

  9. KIM JY, Ou JJ
    Regulation of Apolipoprotein E Trafficking by Hepatitis C Virus-induced Autophagy.
    J Virol. 2018 Apr 25. pii: JVI.00211-18. doi: 10.1128/JVI.00211.
    PubMed     Text format     Abstract available

  10. DE OLIVEIRA CARNEIRO I, Sander AL, Silva N, Moreira-Soto A, et al
    A novel marsupial hepatitis A virus corroborates complex evolutionary patterns shaping the genus Hepatovirus.
    J Virol. 2018 Apr 25. pii: JVI.00082-18. doi: 10.1128/JVI.00082.
    PubMed     Text format     Abstract available

  11. MATSUI C, Deng L, Minami N, Abe T, et al
    Hepatitis C virus NS5A protein promotes the lysosomal degradation of hepatocyte nuclear factor 1alpha via chaperone-mediated autophagy.
    J Virol. 2018 Apr 25. pii: JVI.00639-18. doi: 10.1128/JVI.00639.
    PubMed     Text format     Abstract available


  12. CHEN S, Li J, Wang D, Fung H, et al
    The hepatitis B epidemic in China should receive more attention.
    Lancet. 2018;391:1572.
    PubMed     Text format    

    PLoS One

  13. FISHER KA, Cahill LM, Broyles S, Rorke M, et al
    Knowledge of hepatitis C status moderates the relationship between history of drug treatment and sterile syringe use.
    PLoS One. 2018;13:e0196157.
    PubMed     Text format     Abstract available

  14. CHIU YM, Lai MS, Chan KA
    Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.
    PLoS One. 2018;13:e0196210.
    PubMed     Text format     Abstract available

  15. WASITTHANKASEM R, Vichaiwattana P, Siripon N, Posuwan N, et al
    Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study.
    PLoS One. 2018;13:e0196301.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.